Day: November 20, 2025

• Indeed reports a sharp decline in tech job postings, especially in data and analytics.
• There are 40% fewer data and analytics job postings compared to before the pandemic boom.
• Rising applications and generative AI make this part of the job market highly competitive.

Indeed, the world’s largest job site, just released its big annual study. The data on tech jobs is pretty gruesome. The outlook for data and analytics jobs is particularly grim.

Let’s start with the overall job market. This chart, which includes Indeed’s Job Postings Index, shows a steady decline in available jobs since the pandemic boom of 2022.

Dig deeper, and you can see that the tech job market has done a lot worse than some other sectors. Indeed’s Tech Job Postings Index peaked above 200 in 2022 and has since plunged to 67.

Data and analytics jobs really stand out, though. This sector had a Jobs Posting Index of 60, the lowest of all sectors Indeed tracked as of the end of October. That means there are 40% fewer data and analytics job openings than before the pandemic.

Even worse: There is still a rising number of applications per job in this sector, according to Indeed.

These types of roles include business analyst, data analyst, data scientist, and business-intelligence developer. Indeed’s data shows a clear mismatch between employer demand and worker supply here. Years of investment in data-science training have left a glut of skilled candidates just as hiring appetite cools.

“Workers who received that training are likely to continue to look for jobs that match their skills, regardless of the pullback in postings, because it is often difficult, costly, and time-consuming to change careers,” said Cory Stahle, a senior economist at Indeed.

The pullback in data & analytics jobs has been more dramatic than in other occupations. Employers went on a hiring spree during the post-pandemic boom. Since then, many firms simply haven’t needed to replace these workers as much.

Adding to the chill: the rise of generative AI, which is making it easier for more people to analyze data with less formal training.

“AI is not yet capable of replacing workers, but it may be helping workers and businesses do more with less,” Stahle said.

For job seekers, that translates into a fierce market.

“This combination of fewer postings and more applications suggests that the market is competitive,” Stahle warned. “Finding the right job may take some time, and your wage growth is likely to be weaker than it was a few years in these roles.”

Sign up for BI’s Tech Memo newsletter here. Reach out to me via email at abarr@businessinsider.com.

• Harry Beller worked for Jeffrey Epstein for 22 years as a personal accountant.
• His large cash withdrawals were the subject of at least four JPMorgan Suspicious Activity Reports.
• Congress and lawyers in civil lawsuits want to know about Beller’s role in Epstein’s financial life.

Harry Beller isn’t one of the boldfaced names who can be found all over Jeffrey Epstein’s social calendar and emails, like former Barclays CEO Jes Staley, Bill Clinton, Donald Trump, or Prince Andrew.

But for years, Beller was entrusted with managing some of the most delicate parts of Epstein’s financial life.

Beller was part of a tight-knit team working for Epstein, who killed himself in 2019 while awaiting trial on sex-trafficking charges. He worked under the direction of Richard Kahn, Epstein’s top in-house accountant.

Congressional investigators interested in how Epstein made and spent his money — and whether banks ignored red flags that should have alerted them to sex-trafficking — now have Beller in their crosshairs.

In lawsuits involving Epstein, Beller comes across as something of a financial Forrest Gump — turning up repeatedly in the paper trail. He hasn’t been named as a defendant in any of the lawsuits, but his name crops up on incorporation papers for Epstein’s web of companies, on Ghislaine Maxwell’s tax forms, on checks, and on cash withdrawal records for Epstein’s bank accounts, which for years were held by JPMorgan Chase.

Civil lawsuits say HBRK — a company owned by Epstein and managed by Beller and Kahn — facilitated Epstein’s sex-trafficking operation, although they do not name him or the company as defendants. Beller’s name is on corporate records and tax documents entered into evidence at Maxwell’s criminal trial, at which she was convicted of trafficking girls to Epstein for sex and later sentenced to 20 years in prison.

Democrats on the House Oversight Committee want to subpoena banks for their financial records about Beller and other people who did business with Epstein. Sen. Ron Wyden asked both the Treasury Department and JPMorgan CEO Jamie Dimon to produce records from Epstein-related accounts, including those opened by Beller.

Beller hasn’t been accused of any crimes and there is no record of a federal agency pursuing an enforcement action against him. Through his attorney, Jonathan Sack, Beller declined to comment for this story.

A foot soldier in Epstein’s financial life for 22 years, Beller could help shed light on Epstein’s vast fortune — how he amassed it, and what he did with all his money.

The 69-year-old accountant personally handled some of the cash withdrawals from Epstein’s account, which became a catalyst for Epstein’s messy breakup with JPMorgan years after the financier pleaded guilty to sex crimes in 2008.

Those cash withdrawals should have been a bright red flag for potential financial crimes, such as money laundering, according to Martin Sheil, a former IRS criminal investigator. Beller’s perspective might help explain what Epstein was doing with the money, and what JPMorgan may have known about it at the time.

“Rich folks generally don’t deal in cash, and banks know that,” Sheil told Business Insider.

The cash withdrawals

When JPMorgan decided to cut ties with Epstein in 2013, bank officials said they were concerned with the predator’s frequent cash withdrawals.

Beller was often the person who physically withdrew the cash from Epstein’s accounts, recently unsealed court records show.

He worked for Epstein between 1992 and 2014, and his withdrawals of large amounts of cash from Epstein’s accounts with the bank were the subject of at least four federally mandated Suspicious Activity Reports, or SARs, for concerning transactions. The earliest SAR was filed in 2002 — long before Florida police began investigating Epstein’s abuse of girls.

Banks are typically wary of large cash transactions, since they can exchange hands without clear oversight. “Know Your Customer” rules require financial institutions to monitor where clients’ money is going to ensure it’s not tied to fraud, money laundering, or human trafficking.

Internal JPMorgan communications and copies of the SARs the bank filed with the Treasury Department’s Financial Crimes Enforcement Network show that Beller sometimes withdrew tens of thousands of dollars at a time.

Since JPMorgan believed Epstein was a financial advisor for billionaires, those cash withdrawals should have raised more severe alarms, according to Sheil, the former IRS criminal investigator.

“His business is to provide tax or investment advice to rich, wealthy clients,” Sheil told Business Insider. “And to have this account come in to make these large cash withdrawals? Well, what’s the basis for that? That’s not normal business for an investment advisor.”

In the flagged transactions, Beller always went to the same JPMorgan location: 270 Park Avenue, the bank’s headquarters, which CEO Jamie Dimon recently razed to the ground and replaced with a new office tower for employees.

The repeated visits to the same JPMorgan location should have also raised questions within the bank, said Sarah Krissoff, a former Manhattan federal prosecutor.

“The first time something happens, or the second time, it is going to draw less scrutiny,” said Krissoff, now a white-collar defense attorney at Cozen O’Connor. “As something becomes a pattern, it should be raising more red flags.”

JPMorgan’s SARs became public last month in a now-settled lawsuit between the US Virgin Islands government and the bank.

In the 2002 report, JPMorgan flagged for the Treasury Department that Beller had withdrawn substantial amounts of cash over the span of about three months. The report shows the bank was concerned the withdrawals from Epstein’s accounts could be part of a money laundering operation.

According to the 2002 report, Beller made 16 different cash withdrawals of about $9,800 each (the maximum allowed was $10,000) and cashed one $40,000 check from one of Epstein’s accounts.

Beller — but, not Epstein — was the subject of the 2002 SAR, which a former FBI special agent hired by the US Virgin Islands to analyze the report flagged as unusual.

“If the intention on the part of JPMC was to adequately report the activity, then the SAR would have been filed against Jeffrey Epstein himself, not only against Beller,” the former FBI agent wrote. “Beller was Epstein’s accountant.”

Court records show JPMorgan taking issue with Beller’s cash withdrawals a decade later. An email exchange between bank employees in 2012, obtained in the lawsuit, shows them expressing concern over $100,000 in cash withdrawn from Hyperion Air, a corporate entity that held Epstein’s private jet.

Beller signed the checks for the withdrawals, one employee said. In response, a JPMorgan executive wrote that Epstein said the cash was taken out to pay for fuel in foreign countries, and that the bank ought to check that with Beller.

“Perhaps the next best step is for us to speak with Harry, who we know, and ask Harry about the cash withdrawals,” John R. Duffy, then the CEO of JPMorgan’s private banking division, wrote. “Agree? Concerns?”

It’s not clear from the court documents whether any of the JPMorgan employees ultimately spoke to Beller about the transactions. A separate 2023 report, commissioned by the US Virgin Islands and written by a forensic accountant with access to internal JPMorgan documents, said there’s no evidence the bank ever asked for receipts or other documentation to say the cash was used for fuel.

JPMorgan filed three additional SARs after cutting ties with Epstein in the wake of media reports about the pedophile. In 2015, the bank flagged transactions between 2006 and 2007, the years Florida law enforcement investigated his sexual abuse of teenage girls. The bank filed two other SARs in August and September of 2019, after Epstein’s arrest on federal sex-trafficking charges and death. They covered transactions between 2003 and 2019 in accounts belonging to Epstein as well as several of his associates, including Beller.

“We regret any association we had with the man, but wouldn’t have kept him as a client had we known of his heinous crimes,” JPMorgan Chase spokesperson Patricia Wexler told Business Insider. “The Federal government had much more information on his activities that they did not share with us at the time.”

Following a Truth Social post from Trump on Friday, Attorney General Pam Bondi announced that the US Attorney’s office in Manhattan would investigate JPMorgan’s relationship with Epstein, along with several prominent Democrats with ties to the pedophile.

Epstein’s money man

A pair of lawsuits filed earlier this year by Epstein victims against banks allege Epstein used HBRK to set up fake companies, send hush money and other illegal payments to his sex-trafficking victims, and “otherwise develop false schemes to protect the operation and control the victims.”

The suits say HBRK stands for Harry Beller and Richard Kahn, its “founding members” and longtime Epstein accountants. Like Beller and HBRK, Kahn is not named as a defendant in those lawsuits.

Kahn has managed the affairs of the $630 million estate Epstein left after his 2019 death, along with the financier’s longtime personal lawyer Darren Indyke. An attorney for the co-executors didn’t immediately respond to Business Insider’s request for comment for this story.

Beyond Epstein’s operations, testimony from Beller could give the public a glimpse of the kind of financial advice Epstein gave to his handful of billionaire clients.

Those clients, including former Victoria’s Secret CEO Les Wexner and ex-Apollo CEO Leon Black, have said Epstein provided valuable services to manage their own fortunes. Epstein’s work for Black helped the billionaire save as much as $2 billion in taxes, for which Epstein was compensated around $170 million.

On his LinkedIn page, Beller described his time working for Epstein — which is listed as from 1992 to 2014 — as work for “New York Strategy Group LLC.” Court records describe the company as Epstein’s money management firm. On Beller’s LinkedIn page, it’s described as “a financial advisory firm servicing high net worth individuals with assets in excess of 1 billion dollars.” Beller, who retains a CPA license and lives in upstate New York, now works at a small NYC-based accounting firm.

Sigrid McCawley, an attorney at Boies Schiller Flexner who brought the lawsuits against the banks on behalf of Epstein victims, said Beller was someone who “knows the inner workings” of how Epstein used the financial system.

“He was the accountant part of that enterprise, with Khan, whose hands are all over this,” McCawley told Business Insider. “So I do think he is a significant person of interest in this.”

Beller was forced to testify last year in a deposition in another lawsuit brought by McCawley, against Indyke and Kahn.

When asked about HBRK, he “invoked the Fifth Amendment instead of responding to document subpoenas or substantively answering questions,” McCawley wrote in one court filing.

Forty-five thousand dollars: That’s our best estimate of what the first year of cancer costs in your mid-30s. It’s the equivalent of a first-time down payment on a house, a master’s degree, or two years of childcare in an expensive city.

Business Insider has spent a year investigating how a surge in young cancer is upending careers, family planning, and household budgets. We found there are few reliable estimates for how much a diagnosis actually costs.

We started with medical bills. Even with insurance, the out-of-pocket costs for surgery, chemotherapy, and specialist visits can run into the thousands of dollars.

And that’s just the beginning. As dozens of adults with cancer have told us, the true cost of a diagnosis goes far beyond itemized hospital bills and prescription receipts.

“I have to spend a lot of money on specialized toothpaste,” said JJ Singleton, who was diagnosed with stage 4 colon cancer at 27. “My mouth is so raw that I can’t use any of the normal flavors.”

Rick Rivers, a 43-year-old father of three, takes vitamins and supplements daily after being diagnosed with colon cancer at 30 and kidney cancer at 37. “I spend close to $400 a month just on the holistic end of it,” he said.

Business Insider consulted with five surgeons and oncologists across the country to map out a typical treatment protocol. We then teamed up with health economists at GoodRx, a drug pricing platform, to estimate out-of-pocket treatment costs for the average patient based on national health survey data. We took into account other costs, such as IVF and physical and mental health therapy, as well as the numerous hidden expenses, from travel back and forth to appointments to the cost of wigs after chemotherapy.

To lay this all out in the simplest possible terms, we created a case study. We’re calling her Jane.

Meet Jane: A 35-year-old with stage 3 colon cancer

Jane’s costs reflect the average out-of-pocket expenses for a working-age patient with colon cancer who has some form of insurance coverage.

Colon cancer is one of the fastest-rising cancers for people under 50 — a statistic that triggered Business Insider’s initial reporting on the topic — and it’s often caught at stage 3 or later, when the cancer has spread to nearby lymph nodes.

That’s because the early symptoms of colon cancer are subtle and can be mistaken for other digestive issues, like irritable bowel syndrome. While the recommended age for colonoscopies was recently adjusted down to 45, it’s less likely to be on the radar of someone in their 30s.

Since chemotherapy typically leads to fertility issues, we have factored in the cost of egg freezing. It’s one of the factors that distinguishes young cancer from cancer in older adults: People in their 20s and 30s often still want children.

We also accounted for the hit cancer will take to Jane’s career and long-term finances.

The direct, tangible expenses

For a diagnosis like Jane’s, doctors generally recommend surgery to remove all or some of the colon. Most patients will need to stay at the hospital for two to seven days after the procedure. A small number will require a temporary or permanent ostomy, a surgical intervention that diverts the flow of waste to a bag outside the body, which brings long-term medical supply costs.

The next step will be chemotherapy. The typical chemo treatment runs for three months, with drugs administered every two or three weeks. Some patients with more invasive tumors will need six months of chemo. A patient with a colon cancer diagnosis like Jane is unlikely to need radiation.

Patients will typically be prescribed other drugs, like prochlorperazine to alleviate nausea, and oxycodone to ease pain. Here, Jane’s relative youth is a benefit: Young people tend to tolerate chemo better and recover faster than older adults with cancer.

Jane will also need to keep up with her insurance, which significantly reduces patients’ out-of-pocket burden. A 30-day supply of the chemo drug fluorouracil will cost $5.81 with insurance, or $853.53 for a patient who is uninsured or whose insurance doesn’t cover it, GoodRx’s analysis shows.

However, maintaining that insurance can be expensive. The average American with employer health insurance spent $1,440 in premium costs for individual coverage in 2025. That jumped to $6,850 for family coverage — on top of baseline deductibles and copays. Premiums for both private and public health insurance are set to increase in 2026.

Overall, Jane will incur $5,787 in out-of-pocket healthcare costs, based on our analysis of the average expenses for a working-age adult with her diagnosis. Some of the core cancer costs included in that estimate would be:

• Inpatient surgery and a hospital stay: $550
• Follow-up tests, scans, and outpatient appointments: $0 (Covered by insurance)
• Specialist visits: $576, which will cover six total appointments

• Cancer drugs like chemotherapy: $45

Family planning expenses

Most adults who go through chemo will lose their fertility.

Jane may decide to freeze and store her eggs — preserving the option of having kids via IVF in the future — before starting cancer treatment. That requires more medications and doctors’ visits, and could cost her $20,000 because many insurance plans don’t cover fertility procedures.

Over the next few years, Jane could owe thousands more for longer-term egg storage and IVF cycles.

Men with cancer may choose to preserve their fertility via sperm banking, which can have an initial cost between $500 and $1,000.

The unexpected expenses

As a 35-year-old woman, Jane’s chemo treatments will likely push her into early menopause. To manage her symptoms, she may opt for hormone replacement therapy, which can run up to $500 for a three-month supply.

Beyond medical bills, Jane will have to contend with all the hidden costs of her diagnosis.

DoorDash for dinners she’s too tired to cook, mental health therapy to cope with medical trauma, physical therapy to rebuild strength, clothing and mobility aids to fit a body changed by treatment, vitamins, supplements, and so much more.

She may need to stay at a hotel or an Airbnb near the hospital, or budget for the gas she burns driving back and forth to appointments. Then there are small comforts — manicures, craft kits, a Netflix subscription to boost morale during painful procedures.

“All of this adds up and can be pretty devastating,” says Dr. Krista Terracina, a colorectal surgeon at the University of Florida.

Career costs

Throughout her treatment and recovery, it’s likely that Jane will need to take sick days and reduce her work commitments. GoodRx’s analysis estimates that the average working-age colon cancer patient misses the equivalent of 26 days of work due to cancer and loses an average of $5,104 in annual wages.

The data also shows that younger patients tend to miss more days of work and lose thousands more in wages compared to older patients, since more adults under 50 are working, and they tend to be at a point in their career where they are working more demanding jobs.

It’s possible that Jane will have to scale back to part time, pass up a promotion that comes with a more demanding workload, or stop working altogether.

Each option limits her income, puts her insurance coverage at risk, and could hinder her future goals. Several patients have told Business Insider they nearly drained their savings and 401(k) accounts to afford care.

Elective treatments

Jane may choose to undergo experimental treatments, and it’s likely she’ll have to pay for them in full.

Medicine often needs to be on the market for years, through a series of trials and government approvals, before insurers will cover the cost. The out-of-pocket costs range so widely that we left this out of our estimate.

Immunotherapy, for example, can help destroy cancer cells and reduce the risk of recurrence, and is sometimes used if the baseline course of treatment isn’t effective.

A T-cell transfer, which uses a patient’s own immune system to develop individualized medicine, can cost $373,000 per infusion. Scalp cooling, another emerging treatment used to preserve patients’ hair during chemo, typically costs about $2,000.

Clinical trials are also an option for some patients. If Jane qualifies for one, she might still be responsible for copays, travel, and hospital costs — even if the medicine used in the trial itself is free. Still, volunteering to test drugs and procedures not yet on the broader market is sometimes the only way patients can afford this kind of care. Experimental treatments might bring Jane’s out-of-pocket medical cost to six figures, but they could be lifesaving.

The true cost of young cancer

Jane’s case is hypothetical. Every patient’s experience — and cost — is different. Some Americans have generous insurance coverage, others have limited plans or none at all. Whether or not Jane is a parent, is able to share costs with a partner, or lives near a hospital will also impact what she owes. It may be more or less than Business Insider’s $45,000 benchmark.

After that first year of treatment ends, the bills don’t. Jane will need years of follow-up scans, colonoscopies, and possibly prescriptions to prevent recurrence — each with its own copay. Mental health therapy, too, can become a lifelong expense.

A cancer history can shadow her financial life. While health insurance companies can’t charge patients more for a pre-existing condition, a cancer history can spike Jane’s life insurance premium, or make her ineligible for coverage. Medical debt lingers; roughly half of cancer patients owe money long after remission. It could also drag down her credit score, making it harder to get a loan and rent or buy a home. A young diagnosis will cost the average person $250,000 over their lifetime, one 2021 Deloitte report found.

Because she’s young, Jane faces a higher lifetime risk of recurrence or other cancers. “Secondary malignancy risk is a real thing,” Dr. Andrea Tufano-Sugarman, a gynecologic oncologist at Memorial Sloan Kettering Cancer Center, said. “Our young cancer patients have a fourfold increase in their risk of getting another cancer compared to the general population.”

But the most profound costs can’t be measured in dollars.

“The hidden cost to the epidemic of cancer in younger people is the lost years of productivity, socialization, and family formation,” Terracina said. “It’s all being sucked into a struggle to stay alive.”